scispace - formally typeset
J

Jacqueline Joza

Researcher at McGill University Health Centre

Publications -  51
Citations -  657

Jacqueline Joza is an academic researcher from McGill University Health Centre. The author has contributed to research in topics: Medicine & Atrial fibrillation. The author has an hindex of 11, co-authored 39 publications receiving 442 citations. Previous affiliations of Jacqueline Joza include McGill University.

Papers
More filters
Journal ArticleDOI

Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome

TL;DR: Substrate-guided ablation is an effective approach in the treatment of VT with long-term outcome directly related to acute procedural success, and success rates are significantly lower in patients with NIDCM compared with those with ICM.
Journal ArticleDOI

Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation.

TL;DR: A systematic review of the literature identified 106 articles that investigated the presence of LAA thrombi in nonvalvular atrial fibrillation (AF) patients as mentioned in this paper, and classified the articles according to topic and reported on: (1) risk factors; (2) diagnostic imaging modalities; (3) prevention strategies before cardioversion; (4) prevention strategy before AF ablation; and (5) management of detected LAA Thrombi.
Journal ArticleDOI

Temporal trends and sex differences in pulmonary vein isolation for patients with atrial fibrillation

TL;DR: The uptake of AF ablation over 10 years has expanded, with an increasingly greater number of older patients and with increased presence of comorbidities; however, there has been no increase in the relatively low proportion of women undergoingAF ablation.
Journal ArticleDOI

Managing novel oral anticoagulants in patients with atrial fibrillation undergoing device surgery: Canadian survey.

TL;DR: Most Canadian centres perform device implantation with NOAC interruption without the use of bridging, and the timing of stopping and restarting anticoagulation and incidence of bleeding complications is variable.